Related references
Note: Only part of the references are listed.Risk of Hepatocellular Carcinoma After Sustained Virological Response in Veterans With Hepatitis C Virus Infection
Hashem B. El-Serag et al.
HEPATOLOGY (2016)
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Fabio Conti et al.
JOURNAL OF HEPATOLOGY (2016)
Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment
Karin Kozbial et al.
JOURNAL OF HEPATOLOGY (2016)
Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection
Hidenori Toyoda et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C-Associated Liver Cirrhosis
Soo Aleman et al.
CLINICAL INFECTIOUS DISEASES (2013)
Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study
Eiichi Ogawa et al.
JOURNAL OF HEPATOLOGY (2013)
A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy
Kuo-Chin Chang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and FibroTest
Adays Vallet-Pichard et al.
HEPATOLOGY (2007)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy
H Tokita et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
M Ikeda et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy
Y Iwasaki et al.
LIVER INTERNATIONAL (2004)
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy
A Makiyama et al.
CANCER (2004)
Share Paper
